Remote skin self‐examination training of melanoma survivors and their skin check partners: A randomized trial and comparison with in‐person training

Background Compared with other cancers, melanoma has the longest delays measured as the median time to patient presentation for care from symptom onset. Time to presentation for care is a key determinant of outcomes, including disease stage, prognosis, and treatment. Methods Melanoma survivors with...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2020-10, Vol.9 (19), p.7301-7309
Main Authors: Robinson, June K., Reavy, Racheal, Mallett, Kimberly A., Turrisi, Rob
Format: Article
Language:English
Subjects:
Biopsy
Cancer Prevention
Clinical trials
Enrollments
Intervention
Melanoma
melanoma survivors
Original Research
Participation
Patients
remote training
Scalp
Skin
Skin diseases
skin self‐examination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Compared with other cancers, melanoma has the longest delays measured as the median time to patient presentation for care from symptom onset. Time to presentation for care is a key determinant of outcomes, including disease stage, prognosis, and treatment. Methods Melanoma survivors with localized disease and their skin check partners enrolled in two sequential randomized control trials of skin self‐examination (SSE) training. In Phase 1, the pair read a workbook in the office and had quarterly total body skin examinations with a study dermatologist. In Phase 2, materials were mailed to pairs, whose surveillance was with a community physician. SSE knowledge, performance (frequency and extent), and identification of concerning moles were compared between phases. Results Among 341 patients, 197 received the workbook and the others were controls. Knowledge in performing SSE was higher for the workbook relative to controls in both phases. The SSE frequency ranged from 2.38 to 5.97 times in 9 months. Patients randomized to the workbook in both phases performed significantly more SSE than controls at 9 months (P 
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.3299